Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-24-017900
Filing Date
2024-10-24
Accepted
2024-10-24 16:08:22
Documents
2
Group Members
KEVIN TANGTANG CAPITAL PARTNERS III, INCTANG CAPITAL PARTNERS IV, INCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 mnpr1024240sc13.htm SC 13G 122901
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 12079
  Complete submission text file 0001214659-24-017900.txt   136708
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001232621 (see all company filings)

EIN.: 461592449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Subject) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94081 | Film No.: 241392705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)